Omicron breakthrough infected individuals show enhanced nasal antibody responses and preserved T cell responses against the EG.5.1 and BA.2.86
J Med Virol
.
2024 Mar;96(3):e29537.
doi: 10.1002/jmv.29537.
Authors
Zheng Zhu
1
,
Shixiong Li
2
3
,
Junhao Fan
2
,
Shihao Shang
1
,
Yao Zhang
2
4
,
Qiong Zi
2
,
Jihao Zheng
2
,
Dongfang Wang
2
,
Xiaoli Mou
2
,
Kepu Liu
1
,
Maoxin Lv
5
,
Jianlin Yuan
1
,
Zhongfang Wang
2
6
,
Jingyou Yu
2
6
Affiliations
1
Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
2
Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong Province, China.
3
College of Life Sciences, Nankai University, Tianjin, China.
4
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
5
Department of Urology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
6
State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
PMID:
38497465
DOI:
10.1002/jmv.29537
No abstract available
Publication types
Letter
MeSH terms
Antibody Formation*
Humans
T-Lymphocytes*
Grants and funding
NSFC 82371831
HJJH22-004
GZNL2023A01009
GZNL2023A01005